Antiplatelet and Antithrombotic Effects of Orbofiban, a New Orally Active GPIIb/IIIa Antagonist, in Guinea Pigs

By Ogawa T.   Sugidachi A.   Naganuma H.   Asai F.  

Thrombosis Research, Vol. 97, Iss. 5, 2000-03 ,pp. : 307-315

Elsevier

Access to resources Recommend Favorite

EFFECTS OF TAK-029, A NOVEL GPIIb/IIIa ANTAGONIST, ON ARTERIAL THROMBOSIS IN GUINEA PIGS, DOGS AND MONKEYS

By Kawamura M.   Tsuji N.   Moriya N.   Terashita Z.-i.  

Thrombosis Research, Vol. 86, Iss. 4, 1997-05 ,pp. : 275-285

Elsevier

Access to resources Recommend Favorite

Comparison of the Antithrombotic Effects of FK633, GPIIb/IIIa Antagonist, and Aspirin in a Guinea Pig Thrombosis Model - Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients

By Aoki T.   Cox D.   Senzaki K.   Seki J.   Tanaka A.   Takasugi H.   Motoyama Y.  

Thrombosis Research, Vol. 89, Iss. 3, 1998-02 ,pp. : 129-136

Elsevier

Access to resources Recommend Favorite

Intranasal Antiplatelet/ Antithrombotic Efficacy of a Novel Platelet GPIIB/IIIA Receptor Antagonist DMP755 - a model for in vivo evaluation of antithrombotic agents

By Mousa S.A.   Mu D.-X.   Hussain M.A.  

Thrombosis Research, Vol. 92, Iss. 3, 1998-11 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Comparison of the Antithrombotic Effects and Bleeding Risk of Fractionated Aurin Tricarboxylic Acid and the GPIIb/IIIa Antagonist GR144053 in a Hamster Model of Stenosis

By Ito T.   Matsuno H.   Kozawa O.   Niwa M.   Sakai N.   Uematsu T.  

Thrombosis Research, Vol. 95, Iss. 1, 1999-07 ,pp. : 49-61

Elsevier

Access to resources Recommend Favorite